G01N 2333/4709
Amyloid plaque core protein
G01N2333/4709 (Amyloid plaque core protein) appears on 502 US grants and 976 published applications in this corpus.
Search patents in G01N- Granted patents
- 502
- Published applications
- 976
- Assignees
- 519
- Inventors
- 1,889
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 2 | 0 |
| 1989 | 1 | 0 |
| 1990 | 5 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 7 | 0 |
| 1994 | 1 | 0 |
| 1995 | 6 | 0 |
| 1996 | 5 | 0 |
| 1997 | 11 | 0 |
| 1998 | 8 | 0 |
| 1999 | 8 | 0 |
| 2000 | 6 | 0 |
| 2001 | 18 | 4 |
| 2002 | 17 | 28 |
| 2003 | 8 | 27 |
| 2004 | 10 | 24 |
| 2005 | 9 | 30 |
| 2006 | 12 | 23 |
| 2007 | 7 | 32 |
| 2008 | 10 | 25 |
| 2009 | 12 | 47 |
| 2010 | 17 | 36 |
| 2011 | 13 | 46 |
| 2012 | 11 | 34 |
| 2013 | 14 | 42 |
| 2014 | 21 | 37 |
| 2015 | 29 | 46 |
| 2016 | 18 | 64 |
| 2017 | 35 | 48 |
| 2018 | 23 | 61 |
| 2019 | 28 | 49 |
| 2020 | 31 | 34 |
| 2021 | 22 | 41 |
| 2022 | 21 | 44 |
| 2023 | 13 | 33 |
| 2024 | 12 | 38 |
| 2025 | 14 | 49 |
| 2026 | 16 | 34 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Tau epitope and binding molecules25 Aug 2026US 12,715,908 B2Gen2 Neuroscience Limited
- Amyloid-binding compounds and methods of use thereof21 Jul 2026US 12,687,540 B2Vanderbilt University
- Binding molecule binding to traumatic brain injury-associated tau and methods of use thereof23 Jun 2026US 12,662,678 B2Arizona Board of Regents on behalf of Arizona State University
- Monoclonal antibody against amyloid beta, and method for measuring amyloid beta-related peptide using said antibody9 Jun 2026US 12,650,435 B2Shimadzu Corporation
- Systems and methods for disease diagnosis26 May 2026US 12,635,932 B2Retispec Inc.
- A nasal fluid sample comprising abeta, ptau and/or ttau8 Oct 2026US 2026/0309725 A1Noselab GmbH
- Hyperspectral Image-Guided Ocular Imager for Alzheimer's Disease Pathologies1 Oct 2026US 2026/0294329 A1Retispec Inc.
- Method for measuring polypeptide aggregate, calibrator, complex, and method for producing the same1 Oct 2026US 2026/0298944 A1Sysmex Corporation
- Method for the in vitro diagnosis of a neurodegenerative disease1 Oct 2026US 2026/0298947 A1Institut National de la Sante et de la Recherche Medicale
- Method and device for estimating amount of tau protein accumulation in subject's brain24 Sep 2026US 2026/0287581 A1National Institutes for Quantum Science and Technology
Most cited
By later US patents
- Methods for the detection of soluble .beta.-amyloid peptide244US 5,593,846 AAthena Neurosciences, Inc. · 1997
- Methods for monitoring cellular processing of .beta.-amyloid precursor protein167US 5,441,870 AAthena Neurosciences, Inc. · 1995
- Methods of screening for compounds which inhibit soluble .beta.-amyloid peptide production152US 5,766,846 AAthena Neurosciences, Inc. · 1998
- Transgenic animals harboring APP allele having swedish mutation142US 5,612,486 AAthena Neurosciences, Inc. · 1997
- Antibodies and fragments thereof which bind the carboxyl-terminus of an amino-terminal fragment of .beta.APP114US 5,721,130 AAthena Neurosciences, Inc. · 1998